Bio Usawa

San Francisco, United States

Bio Usawa is a biotechnology company that develops monoclonal antibodies for cancer, ophthalmic, and infectious diseases.

$500K raised

Dec 2025

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bio Usawa

How much funding has Bio Usawa raised?

Bio Usawa has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.

Where is Bio Usawa headquartered?

Bio Usawa is headquartered in San Francisco, United States.

What does Bio Usawa do?

Bio Usawa is a biotechnology company that develops monoclonal antibodies for cancer, ophthalmic, and infectious diseases.

What stage is Bio Usawa at?

Bio Usawa is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 17, 2025.

MLA

"Bio Usawa — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/bio-usawa. Accessed July 5, 2026.

APA

VCBacked. (2025). Bio Usawa — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/bio-usawa

Wikipedia (cite web)

{{cite web |title=Bio Usawa — Funding & Investors |url=https://www.vcbacked.co/company/bio-usawa |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 17, 2025.